This site is intended for patients and caregivers in Australia

Capsule CMI

Tablet CMI

Capsule CMI

Tablet CMI

  • Home
  • About CLL/SLL
  • About MCL
  • Taking CALQUENCE®
    • Taking CALQUENCE®
    • How CALQUENCE® Works
    • Need to Know
    • Dosing with CALQUENCE®
    • Side-Effects with CALQUENCE®
    • Travelling with CALQUENCE®
    • Tracking your Progress
    • Tips for your Doctor's Appointment
  • Patient Support
  • Caregiver Resources
  • Additional Support
 
 

CALQUENCE® is a registered trademark of the AstraZeneca group of companies.
Registered user AstraZeneca Pty. Ltd. ABN 54 009 682 311. 66 Talavera Road,
Macquarie Park, NSW 2113. www.astrazeneca.com.au.
For Medical Information enquiries or to report an adverse event or product quality complaint:
Telephone 1800 805 342 or via https://contactazmedical.astrazeneca.com. Or email
Medical Information enquiries to medinfo.australia@astrazeneca.com. AU-16870, February 2025.

  • Legal Notice & Terms of Use
  • Contact Us
  • Privacy Notice
  • Cookie Policy
 
 

CONTACT US

If you require assistance, please contact Medical Information at AstraZeneca Australia on

1800 805 342
Monday to Friday
(9am - 5pm AEST/AEDT)